Healthcare provider profile · identity verified

Ashley Suzanne Millham, M.D.

Family Practice · COLUMBIA, MO · NPI 1306132808

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	251	70
Levothyroxine Sodium	Levothyroxine Sodium	235	70
Amlodipine Besylate	Amlodipine Besylate	231	62
Rosuvastatin Calcium	Rosuvastatin Calcium	205	57
Omeprazole	Omeprazole	169	35
Pantoprazole Sodium	Pantoprazole Sodium	158	44
Losartan Potassium	Losartan Potassium	144	41
Gabapentin	Gabapentin	135	31
Sertraline Hcl	Sertraline Hcl	124	33
Lisinopril	Lisinopril	113	35
Metoprolol Succinate	Metoprolol Succinate	85	26
Potassium Chloride	Potassium Chloride	84	22
Albuterol Sulfate Hfa	Albuterol Sulfate	73	24
Hydrochlorothiazide	Hydrochlorothiazide	72	20
Jardiance	Empagliflozin	72	20
Tamsulosin Hcl	Tamsulosin Hcl	69	22
Metformin Hcl Er	Metformin Hcl	65	19
Montelukast Sodium	Montelukast Sodium	65	20
Eliquis	Apixaban	60	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	22
Doxepin Hcl	Doxepin Hcl	56	14
Fluticasone Propionate	Fluticasone Propionate	54	17
Duloxetine Hcl	Duloxetine Hcl	51	16
Furosemide	Furosemide	50	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	13
Atenolol	Atenolol	49	14
Diclofenac Sodium	Diclofenac Sodium	47	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	14
Trazodone Hcl	Trazodone Hcl	44	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Tramadol Hcl	Tramadol Hcl	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Estradiol	Estradiol	33	14
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Famotidine	Famotidine	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	11
Trulicity	Dulaglutide	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Baclofen	Baclofen	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Metformin Hcl	Metformin Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Prednisone	Prednisone	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Diazepam	Diazepam	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Simvastatin	Simvastatin	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Asenapine Maleate	Asenapine Maleate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Praluent Pen	Alirocumab	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lactulose	Lactulose	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error